Knight Closes $100MM Revolving Credit Facility
Knight Therapeutics, a pan-American (ex-U.S.) specialty pharmaceutical company, closed the syndication of its $100 million secured revolving credit facility. Previously, Knight closed a $50 million revolving credit facility with National Bank of Canada (NBC) and initiated a syndication process to...
Read moreDetails









